Background: Diabetes is amongst the most researched diseases worldwide due to its debilitating effects on patients. Diabetics have a higher risk of developing erectile dysfunction. Evidence has linked erectile dysfunction severity to increased age, duration of diabetes, the metabolic syndrome and hypogonadism. However, the role of inflammatory markers in the pathogenesis of SD is still unclear. The contributions of hormonal parameters and adipokines to both macro and micro vascular complications are still poorly understood. This study was conducted to provide some evidence of an association between SD, the metabolic syndrome and inflammatory hormones. Method: A total of 130 diabetic males participated in this study. All participants were at least 18 years and were actively engaged in a stable heterosexual relationship for a minimum of two years before they were recruited for this study. The Diabetic men were evaluated using the Golombok Rust Inventory of Sexual Satisfaction for males (GRISS-M). The NCEP-ATP III, IDF and WHO criteria were used to assess the metabolic syndrome. Blood samples were taken for biochemical and hormonal assays. Results: Participants with raised Triglyceride levels showed significantly higher leptin levels for NCEP-ATP III and IDF criteria. Participants with impotence showed significantly lower leptin/adiponectin ratio (p = 0.0184) whilst participant with non-sensuality showed significantly higher values of leptin/adiponectin ratio (p = 0.0103). A significantly higher levels of insulin (p = 0. 
Introduction
Diabetes is one of the most researched diseases in the world due to its debilitating effects on patients and the many complications that could result from this disease. The number of people with diabetes is known to be increasing due to population growth, aging, urbanization and increasing prevalence of obesity and physical inactivity [1] . Diabetics are reported to have a higher risk of developing erectile dysfunction (ED) [2] [3] [4] , sexual dysfunction (SD) [5] [6] and other cardiovascular pathologies [6] [7] . Evidence has linked erectile dysfunction severity to increased age [8] and duration of diabetes [8] , poor glycaemic control and cardiovascular disease [8] as well as the metabolic syndrome [9] . Chronic hyperglycaemias as well as dyslipidaemia underpinned by endothelial dysfunction are the major underlying biochemical factors in diabetes [10] . The contribution of these abnormalities to both macro and micro vascular complications is well known, however their contribution to SD or specific domains of SD and which specific pathophysiological mechanism are implicated is still open to debate. Furthermore, the pathophysiological role of inflammatory hormones and their roles in the development or worsening of SD and the MetS is still not clearly understood.
The metabolic syndrome (MetS) is also characterized by a cluster of factors such as hyperglycemia, dyslipidaemia, high blood pressure, obesity and insulin resistance and these have long been implicated in the causation or worsening of diabetes [11] . Similarities in aetiology of the MetS with diabetes as well as SD can be traced to endothelial dysfunction and it is therefore not surprising that an increased prevalence of SD and MetS is largely reported to be among diabetics [9] . Although the pathophysiology is incompletely understood, insulin resistance and abdominal obesity are central to subsequent abnormalities in circulating glucose and lipoproteins and vascular function that lead to type 2 diabetes, atherosclerosis and CVD [12] . Various researches have attempted to elucidate the relationship between SD, MetS, inflammatory markers and some hormonal parameters which are likely to influence this relationship with some evidence showing a positive association between fasting insulin levels and inverse relationship between free testosterone levels, SHBG and the development of diabetes [13] . Some research has shown that age related decrease in testosterone levels is significantly exacerbated in obese men with the metabolic syndrome [14] but the role of inflammatory hormones is yet to be fully elucidated. It is in this light that this research seeks to provide some evidence of an association between MetS, SD and some hormonal parameters which are potential markers of inflammation. This research therefore seeks to determine if there are differences in the measured hormonal parameters between subjects with and without SD and/or the MetS.
Adipocytes play an important role in regulating triglycerides and free fatty acids levels [15] . High levels of androgens drive differentiation towards myogenesis and thus inhibit adipogenesis [16] . Thus androgen levels as well as levels of hormones produced by these adipocytes are likely to influence the development of the MetS in both sexes. A plausible biological mechanism for obesity induced hypogonadism may result in part from increased feedback inhibition of the hypothalamic-pituitary axis due to high levels of estrogen in obese men [17] .
The Third National Health and Nutrition Examination Survey [17] reported that low free and bioavailable testosterone concentrations in the normal range were associated with diabetes, independent of adiposity. They suggested that low androgen levels may be a risk factor for diabetes in men. In a multivariable model adjusted for age, ethnicity and adiposity they observed that men in the first tertile (lowest) of free testosterone level were four times more likely to have prevalent diabetes compared with men in the third tertile. Similarly, men in the first tertile of bioavailable testosterone also were approximately four times as likely to have prevalent diabetes compared with men in the third tertile, these associations persisted even after excluding men with clinically abnormal testosterone concentrations. Others researchers [18] have demonstrated that the relationship between testosterone levels and adiposity is even dose dependent, with the effect of a 5 mg testosterone patch on body fat reduction being less in comparison to a 100 mg testosterone patch administered over the course of three months. They also showed that treatment with testosterone gel improved sexual function and mood, lean and fat mass as well as bone mineral density in hypogonadal men. Whether these established effects of testosterone on sexual function and body adiposity markers is mediated or influenced by inflammatory markers is still open to debate.
Methods
A total of 130 diabetic males who were attending the diabetic clinic and managed on oral diabetic medications at the Maamobi General Hospital in Accrabetween October, 2013 to September, 2014 were recruited for this study. Participants were consecutively sampled and those who were at least 18 years and were actively engaged in a stable heterosexual relationship were enrolled in the study. 
Statistical Analysis
All data analysis were performed using the SPSS software, version 11.0 systat, Inc. Germany and GraphPad Prism, version 5.0, San Diego California, USA.
Data presentation was done as the mean ±SD or percentages. In all the statistical analysis, a value of p < 0.05 was considered to be significant.
Results
The age range for those who responded was between 29 to 89 years, with a mean age of 63.04 ± 10.85 years and a mean duration of diabetes of 8.38 ± 6.53 years. Table 1) .
The mean insulin, adiponectin, leptin and the leptin/adiponectin ratio recorded among the participants was 83.10 ± 22.79 pg/ml, 1.51± 0.35 ng/ml, 24.23 ± 12.00 ng/ml and 0.02 ± 0.00 respectively (Table 2) . When the study participants were stratified by the MetS using the various criteria, the NCEP-ATP III recorded no significant differences in the insulin, leptin and the leptin/adiponectin ratio between subjects with or without the MetS. However participants with the MetS recorded increased adiponectin levels. The IDF and WHO criteria however did not show any significant difference in any of these parameters amongst subjects with or without the MetS (Table 2) .When the mean values of (Table 3 ).
As shown in Table 4 and and a significantly lower leptin/adiponectin ratio (0.01 ± 0.00 against 0.02 ± 0.01) in comparison to participants without the presence of Dyslipidaemia.
When the diabetic participants were stratified based on the presence or absence of SD domains (Table 6) , participants who had impotence showed significantly lower leptin/adiponectin ratio (0.01 ± 0.00 against 0.02 ± 0.01) but no significant difference in the levels of insulin, adiponectin, leptin whilst participants with the presence of premature ejaculation showed no difference in insulin, adiponectin, leptin and leptin/adiponectin ratios in comparison with subjects without the presence of premature ejaculation. Participants with the presence of non-sensuality showed significantly higher values of leptin /adiponectin ratio (0.03 ± 0.00 against 0.02 ± 0.00) but did not show any significant difference in the levels of insulin, adiponectin and leptin when compared to participants Table 6 . Sexual Dysfunction (SD), SD subscales against hormonal assays. 
Discussion
Subjects with reduced HDL-cholesterol levels recorded higher levels of adiponectin whilst Dyslipidaemia which has reduced HDL-cholesterol levels in its definition also recorded significantly higher levels of adiponectin. This could explain the potential role of adiponectin levels in the pathogenesis of the MetS and possibly diabetes. This is further supported by the observation of higher levels of leptin (ATP/IDF) amongst subjects with raised triglyceride levels which is a cardinal event in the early metabolic derangements involved in the pathogenesis of the MetS. Since raised triglycerides is a marker of increased fatty acid availability, it is possible that higher leptin levels could have triggered the suppression of testosterone levels via leptin receptors present on leydig cells or by the increased aromatization of androgens to oestrogens. This could potentially cause a reduction in the levels of free and bioavailable testosterone in circulation thus inducing a state of hypogonadism. Whether the increased leptin levels in a state of increased abdominal obesity (Table 4) directly results in the reduction in testosterone levels via suppression of production mediated by leptin receptors on leydig cells or by the increased aromatization to oestrogens, reduced testosterone levels could without doubt further promote adipocytosis as decreased testosterone le-vels has been shown to promote adipocytosis in various research. The resultant increase in adipocytes coupled with the hypogonadism could be a major trigger in the events that leads to development of the MetS. Furthermore, as testosterone levels decrease further in the face of persistent increase in adipocytes, Nitric
Oxide (NO) availability could be compromised by direct inactivation of eNOS. A reduction in the availability of NO in the endothelial wall could result in increased free radical damage and increased oxidative stress which will eventually compromise endothelial integrity. As NO availability is compromised in the presence of a progressive and persistently unresolved dyslipidaemic derangements and hyperglycaemia, neuronal glycation coupled with unavailability of NO could trigger the series of events which eventually promotes the progression from the MetS characterised by dyslipidaemia to a competition for the remaining NO.
Thus a vicious cycle could be created between endothelial dysfunction, the MetS and SD. The importance of the fine balance between the levels of adiponectin and leptin is showed by the lower leptin/adiponectin ratio recorded for participants with reduced HDL levels, Dyslipidaemia (Table 4) , Impotence and Non-sensuality (Table 5) and SD. This is also supported by the observation in this study that insulin and adiponectin levels showed significant differences when various shades of MetS/ SD were compared (Table 7) . But the fact that leptin did not show a difference when the various shades of MetS/SD were compared could mean that increased leptin levels could possibly have been an earlier event before the development of both MetS and SD. Thus leptin could have played a significant role in the development of diabetes and thus could not have been varied among a group of diabetics with various shades of MetS/SD but still remained an important mediator as evidenced by the significance in the ratio of leptin to adiponectin seen in this study. Even though none of the assayed hormonal parameters recorded as determinants of SD and the MetS (Table 8) , a longitudinal study which meas-ures a range of both pro and anti-inflammatory hormones and adipokines as risk factors for SD and the MetS could potentially aid in assessing the risk of developing these conditions among diabetics. 
Conclusion
The relative balance between pro inflammatory and anti-inflammatory mediators of endothelial dysfunction could possibly be essential for the progression of diabetes to SD and the MetS thus a longitudinal study which measures a range of both pro and anti-inflammatory hormones and adipokines as risk factors for SD and the MetS could potentially aid in improvements in assessing the risk of developing these conditions among diabetics.
